N-[2-[4-[[8-fluoro-7-(2-methylphenyl)-3-phenylpyrrolo[3,2-e]indazol-6-yl]methyl]phenyl]ethyl]cyclobutanamine
C35H33FN4 — CID 155635039
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[4-[[8-fluoro-7-(2-methylphenyl)-3-phenylpyrrolo[3,2-e]indazol-6-yl]methyl]phenyl]ethyl]cyclobutanamine
N-[2-[4-[[8-fluoro-7-(2-methylphenyl)-3-phenylpyrrolo[3,2-e]indazol-6-yl]methyl]phenyl]ethyl]cyclobutanamine (PubChem CID 155635039) has the molecular formula C35H33FN4 and a molecular weight of 528.68 g/mol. Its IUPAC name is N-[2-[4-[[8-fluoro-7-(2-methylphenyl)-3-phenylpyrrolo[3,2-e]indazol-6-yl]methyl]phenyl]ethyl]cyclobutanamine.
Molecular Properties
| Compound Name | N-[2-[4-[[8-fluoro-7-(2-methylphenyl)-3-phenylpyrrolo[3,2-e]indazol-6-yl]methyl]phenyl]ethyl]cyclobutanamine |
|---|---|
| PubChem CID | 155635039 |
| Molecular Formula | C35H33FN4 |
| Molecular Weight | 528.68 g/mol |
| Exact Mass | 528.27 |
| IUPAC Name | N-[2-[4-[[8-fluoro-7-(2-methylphenyl)-3-phenylpyrrolo[3,2-e]indazol-6-yl]methyl]phenyl]ethyl]cyclobutanamine |
| SMILES | Cc1ccccc1-c1c(F)c2c3cnn(-c4ccccc4)c3ccc2n1Cc1ccc(CCNC2CCC2)cc1 |
| InChI | InChI=1S/C35H33FN4/c1-24-8-5-6-13-29(24)35-34(36)33-30-22-38-40(28-11-3-2-4-12-28)31(30)18-19-32(33)39(35)23-26-16-14-25(15-17-26)20-21-37-27-9-7-10-27/h2-6,8,11-19,22,27,37H,7,9-10,20-21,23H2,1H3 |
| InChIKey | SRBLSGSYOFACPX-UHFFFAOYSA-N |
| XLogP | 7.83 |
| TPSA | 34.78 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 528.68 |
| LogP ≤ 5 | 7.83 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155635039 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.